Since the functional state of TILs is linked to their potential anti-tumor activity, we analyzed the expression of selected activation markers (HLA-DR and CD103) and inhibitory markers (PD-1, TIM-3, and LAG-3). The gene discussed is PDCD1; the disease is neoplasm.